Cargando…

An NPPB Promoter Polymorphism Associated With Elevated N‐Terminal pro–B‐Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and Mortality

BACKGROUND: Elevated B‐type natriuretic peptide (BNP) levels are associated with heart failure and increased mortality in the general population. We investigated rs198389, a functional variant in the promoter region of the BNP gene (NPPB), in patients from the Atherosclerosis Risk in Communities Stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Seidelmann, Sara B., Vardeny, Orly, Claggett, Brian, Yu, Bing, Shah, Amil M., Ballantyne, Christie M., Selvin, Elizabeth, MacRae, Calum A., Boerwinkle, Eric, Solomon, Scott D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533018/
https://www.ncbi.nlm.nih.gov/pubmed/28341776
http://dx.doi.org/10.1161/JAHA.116.005257
_version_ 1783253564158640128
author Seidelmann, Sara B.
Vardeny, Orly
Claggett, Brian
Yu, Bing
Shah, Amil M.
Ballantyne, Christie M.
Selvin, Elizabeth
MacRae, Calum A.
Boerwinkle, Eric
Solomon, Scott D.
author_facet Seidelmann, Sara B.
Vardeny, Orly
Claggett, Brian
Yu, Bing
Shah, Amil M.
Ballantyne, Christie M.
Selvin, Elizabeth
MacRae, Calum A.
Boerwinkle, Eric
Solomon, Scott D.
author_sort Seidelmann, Sara B.
collection PubMed
description BACKGROUND: Elevated B‐type natriuretic peptide (BNP) levels are associated with heart failure and increased mortality in the general population. We investigated rs198389, a functional variant in the promoter region of the BNP gene (NPPB), in patients from the Atherosclerosis Risk in Communities Study to investigate associations with N‐terminal pro‐BNP (NT‐proBNP) levels and outcomes. METHODS AND RESULTS: A total of 11 361 black and white patients with rs198389 genotyping attended visit 1 (aged 45–64 years; 1987–1989), with follow‐up visits occurring every 3 years (visit 2–visit 4, 1990–1999), followed by visit 5 (2011–2013). NT‐proBNP levels were measured at visits 2, 4, and 5. At visit 2, the GG genotype (frequency 18%) was associated with a 41% higher mean plasma level of NT‐proBNP compared with the AA genotype (frequency 34%), with intermediate values observed in AGs (P=4.2×10(−52)). The GG genotype was associated with reduced systolic blood pressure (−1.6 mm Hg, P=0.006), diastolic blood pressure (−1 mm Hg, P=0.003), antihypertension medication use (odds ratio, 0.85; 95% CI, 0.74–0.97 [P=0.02]), and hypertension (odds ratio, 0.81; 95% CI, 0.72–0.92 [P=0.002]) compared with the AA genotype with intermediate values in AGs. These relationships persisted throughout subsequent visits. After a median follow‐up of 23 years, there were 4031 deaths. With and without covariate adjustment, the GG genotype was associated with modestly lower mortality (hazard ratio, 0.86; 95% CI, 0.78–0.95), primarily reflective of cardiovascular death (hazard ratio, 0.75; 95% CI, 0.61–0.92), and increased residual lifespan of 8 months from 50 years of age (P=0.02) versus AAs. CONCLUSIONS: The rs198389 G allele in the NPPB promoter is associated with elevated levels of NT‐proBNP throughout adult life, reduced blood pressure, hypertension and cardiovascular mortality, and increased lifespan.
format Online
Article
Text
id pubmed-5533018
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-55330182017-08-14 An NPPB Promoter Polymorphism Associated With Elevated N‐Terminal pro–B‐Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and Mortality Seidelmann, Sara B. Vardeny, Orly Claggett, Brian Yu, Bing Shah, Amil M. Ballantyne, Christie M. Selvin, Elizabeth MacRae, Calum A. Boerwinkle, Eric Solomon, Scott D. J Am Heart Assoc Original Research BACKGROUND: Elevated B‐type natriuretic peptide (BNP) levels are associated with heart failure and increased mortality in the general population. We investigated rs198389, a functional variant in the promoter region of the BNP gene (NPPB), in patients from the Atherosclerosis Risk in Communities Study to investigate associations with N‐terminal pro‐BNP (NT‐proBNP) levels and outcomes. METHODS AND RESULTS: A total of 11 361 black and white patients with rs198389 genotyping attended visit 1 (aged 45–64 years; 1987–1989), with follow‐up visits occurring every 3 years (visit 2–visit 4, 1990–1999), followed by visit 5 (2011–2013). NT‐proBNP levels were measured at visits 2, 4, and 5. At visit 2, the GG genotype (frequency 18%) was associated with a 41% higher mean plasma level of NT‐proBNP compared with the AA genotype (frequency 34%), with intermediate values observed in AGs (P=4.2×10(−52)). The GG genotype was associated with reduced systolic blood pressure (−1.6 mm Hg, P=0.006), diastolic blood pressure (−1 mm Hg, P=0.003), antihypertension medication use (odds ratio, 0.85; 95% CI, 0.74–0.97 [P=0.02]), and hypertension (odds ratio, 0.81; 95% CI, 0.72–0.92 [P=0.002]) compared with the AA genotype with intermediate values in AGs. These relationships persisted throughout subsequent visits. After a median follow‐up of 23 years, there were 4031 deaths. With and without covariate adjustment, the GG genotype was associated with modestly lower mortality (hazard ratio, 0.86; 95% CI, 0.78–0.95), primarily reflective of cardiovascular death (hazard ratio, 0.75; 95% CI, 0.61–0.92), and increased residual lifespan of 8 months from 50 years of age (P=0.02) versus AAs. CONCLUSIONS: The rs198389 G allele in the NPPB promoter is associated with elevated levels of NT‐proBNP throughout adult life, reduced blood pressure, hypertension and cardiovascular mortality, and increased lifespan. John Wiley and Sons Inc. 2017-03-24 /pmc/articles/PMC5533018/ /pubmed/28341776 http://dx.doi.org/10.1161/JAHA.116.005257 Text en © 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Seidelmann, Sara B.
Vardeny, Orly
Claggett, Brian
Yu, Bing
Shah, Amil M.
Ballantyne, Christie M.
Selvin, Elizabeth
MacRae, Calum A.
Boerwinkle, Eric
Solomon, Scott D.
An NPPB Promoter Polymorphism Associated With Elevated N‐Terminal pro–B‐Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and Mortality
title An NPPB Promoter Polymorphism Associated With Elevated N‐Terminal pro–B‐Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and Mortality
title_full An NPPB Promoter Polymorphism Associated With Elevated N‐Terminal pro–B‐Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and Mortality
title_fullStr An NPPB Promoter Polymorphism Associated With Elevated N‐Terminal pro–B‐Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and Mortality
title_full_unstemmed An NPPB Promoter Polymorphism Associated With Elevated N‐Terminal pro–B‐Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and Mortality
title_short An NPPB Promoter Polymorphism Associated With Elevated N‐Terminal pro–B‐Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and Mortality
title_sort nppb promoter polymorphism associated with elevated n‐terminal pro–b‐type natriuretic peptide and lower blood pressure, hypertension, and mortality
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533018/
https://www.ncbi.nlm.nih.gov/pubmed/28341776
http://dx.doi.org/10.1161/JAHA.116.005257
work_keys_str_mv AT seidelmannsarab annppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality
AT vardenyorly annppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality
AT claggettbrian annppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality
AT yubing annppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality
AT shahamilm annppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality
AT ballantynechristiem annppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality
AT selvinelizabeth annppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality
AT macraecaluma annppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality
AT boerwinkleeric annppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality
AT solomonscottd annppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality
AT seidelmannsarab nppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality
AT vardenyorly nppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality
AT claggettbrian nppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality
AT yubing nppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality
AT shahamilm nppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality
AT ballantynechristiem nppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality
AT selvinelizabeth nppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality
AT macraecaluma nppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality
AT boerwinkleeric nppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality
AT solomonscottd nppbpromoterpolymorphismassociatedwithelevatednterminalprobtypenatriureticpeptideandlowerbloodpressurehypertensionandmortality